219 related articles for article (PubMed ID: 28880764)
1. Comparing the effectiveness and wash-off resistance of skin barrier creams: a healthy volunteer study.
Dykes P; Bradbury S
J Wound Care; 2017 Sep; 26(9):552-557. PubMed ID: 28880764
[TBL] [Abstract][Full Text] [Related]
2. Protecting vulnerable skin from moisture-associated skin damage.
Collier M; Simon D
Br J Nurs; 2016 Nov; 25(20 Suppl):S26-S32. PubMed ID: 27834525
[TBL] [Abstract][Full Text] [Related]
3. Moisture-associated skin damage: use of a skin protectant containing manuka honey.
Woodward S
Br J Nurs; 2019 Mar; 28(6):329-335. PubMed ID: 30925233
[TBL] [Abstract][Full Text] [Related]
4. Effects of a Skin Barrier Cream on Management of Incontinence-Associated Dermatitis in Older Women: A Cluster Randomized Controlled Trial.
Kon Y; Ichikawa-Shigeta Y; Iuchi T; Nakajima Y; Nakagami G; Tabata K; Sanada H; Sugama J
J Wound Ostomy Continence Nurs; 2017; 44(5):481-486. PubMed ID: 28723852
[TBL] [Abstract][Full Text] [Related]
5. Incontinence pad absorption and skin barrier creams: a non-patient study.
Dykes P; Bradbury S
Br J Nurs; 2016 Dec; 25(22):1244-1248. PubMed ID: 27935347
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of topical skin products in the treatment and prevention of incontinence-associated dermatitis: a systematic review.
Pather P; Hines S; Kynoch K; Coyer F
JBI Database System Rev Implement Rep; 2017 May; 15(5):1473-1496. PubMed ID: 28498177
[TBL] [Abstract][Full Text] [Related]
7. Prevention and management of incontinence-associated dermatitis using a barrier cream.
Holroyd S; Graham K
Br J Community Nurs; 2014 Dec; Suppl Wound Care():S32-8. PubMed ID: 25478854
[TBL] [Abstract][Full Text] [Related]
8. An economic evaluation of four skin damage prevention regimens in nursing home residents with incontinence: economics of skin damage prevention.
Bliss DZ; Zehrer C; Savik K; Smith G; Hedblom E
J Wound Ostomy Continence Nurs; 2007; 34(2):143-52; discussion 152. PubMed ID: 17413828
[TBL] [Abstract][Full Text] [Related]
9. A Prospective, Descriptive, Quality Improvement Study to Decrease Incontinence-Associated Dermatitis and Hospital-Acquired Pressure Ulcers.
Hall KD; Clark RC
Ostomy Wound Manage; 2015 Jul; 61(7):26-30. PubMed ID: 26185973
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of a hydrocolloid crusting method versus standard care in the treatment of incontinence-associated dermatitis among adult patients in an acute care setting: A randomised controlled trial.
Gunasegaran N; Ang SY; Ng YZ; Lee NES; Agus N; Lee CW; Ong CE; Mostafa SS; Aloweni F
J Tissue Viability; 2023 May; 32(2):171-178. PubMed ID: 36717288
[TBL] [Abstract][Full Text] [Related]
11. Durability of an Advanced Skin Protectant Compared With Other Commercially Available Products in Healthy Human Volunteers.
Muresan M; Muresan S; Brinzaniuc K; Sala D; Neagoe R
Wounds; 2018 Sep; 30(9):310-316. PubMed ID: 30256746
[TBL] [Abstract][Full Text] [Related]
12. Does skin care frequency affect the severity of incontinence-associated dermatitis in critically ill patients?
Conley P; McKinsey D; Ross O; Ramsey A; Feeback J
Nursing; 2014 Dec; 44(12):27-32. PubMed ID: 25406780
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a new topical skin protectant (RD1433) for the prevention and treatment of incontinence-associated dermatitis.
Matar H; Larner J; Viegas V; Kansagra S; Atkinson KL; Shetage S; Skamarauskas JT; Theivendran B; Goldman VS; Chilcott RP
Cutan Ocul Toxicol; 2017 Sep; 36(3):211-219. PubMed ID: 27817210
[TBL] [Abstract][Full Text] [Related]
14. Management of incontinence-associated dermatitis with a skin barrier protectant.
Southgate G; Bradbury S
Br J Nurs; 2016 May 12-25; 25(9):S20-9. PubMed ID: 27172503
[TBL] [Abstract][Full Text] [Related]
15. Management of incontinence-associated dermatitis patients using a skin protectant in acute care: a case series.
Acton C; Ivins N; Bainbridge P; Browning P
J Wound Care; 2020 Jan; 29(1):18-26. PubMed ID: 31930942
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a Hand Regimen in Skin Barrier Protection in Individuals With Occupational Irritant Contact Dermatitis.
Jordan L
J Drugs Dermatol; 2016 Nov; 15(11):s81-s85. PubMed ID: 28095569
[TBL] [Abstract][Full Text] [Related]
17. A Natural Cream-to-Powder Formulation Developed for the Prevention of Diaper Dermatitis in Diaper-Wearing Infants and Children: Barrier Property and In-Use Tolerance Studies.
Gunt HB; Levy SB; Lutrario CA
J Drugs Dermatol; 2018 May; 17(5):566-570. PubMed ID: 29742190
[TBL] [Abstract][Full Text] [Related]
18. Barrier products in the treatment of incontinence-associated dermatitis.
Lian Y
Nurs Stand; 2016 Jul; 30(47):59-69. PubMed ID: 27440366
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of topical skin products in the treatment and prevention of incontinence-associated dermatitis: a systematic review protocol.
Pather P; Hines S; Kynoch K; Coyer F
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):36-52. PubMed ID: 26455602
[No Abstract] [Full Text] [Related]
20. Incontinence-associated dermatitis: new insights into an old problem.
Voegeli D
Br J Nurs; 2016 Mar 10-23; 25(5):256, 258, 260-2. PubMed ID: 26972998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
